Interactive Strength Inc. (Nasdaq:TRNR) Signs Binding Agreement to Acquire Sportstech, a Profitable $40M+ Revenue Connected-Fitness Equipment Business

February 11, 2025 8:00 AM

AUSTIN, TX / ACCESS Newswire / February 11, 2025 / Interactive Strength Inc. (NASDAQ:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced it had signed a binding transaction agreement to acquire Sportstech Brands Holding GMBH ("Sportstech"), the largest connected fitness and equipment company in Germany. The binding transaction agreement marks an expected milestone in...

Read more

NanoViricides Drug Can Fight Bird Flu Pandemic; H5N1 Virus Cannot Escape

February 11, 2025 6:30 AM

NanoViricides, Inc. (NYSE American:NNVC) (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu virus H5N1 likely cannot escape despite its ability to mutate rapidly with genomic changes.An "opinion and analysis" article published in Scientific American on February 7th correctly recognizes that the H5N1 "virus is versatile…and mutating", although...

Read more

Cytion Strengthens Long-Term Bioz Partnership, Driving User Engagement and SEO Success With AI-Powered Web-Based Digital Widgets

February 11, 2025 4:00 AM

Bioz, Inc., an AI-powered citation management company at the forefront of scientific discovery, is excited to highlight the continued success of its long-term partnership with Cytion, a leading supplier of cell line products. With an impressive implementation of 1,000 Bioz Badges, Cytion is leveraging AI to increase user engagement, enhance search engine visibility, and provide researchers with seamless access to real-world product citations.By...

Read more

BioVersys Successfully Advances Bv500 NTM Program with Continued Support from CF AMR Syndicate

February 11, 2025 1:20 AM

BioVersys AG (SIX:BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by multidrug-resistant (MDR) bacteria, announced today that its BV500 NTM program has reached its second milestone, " identification of up to 5 Optimized Lead compounds", under the CF AMR Syndicate Collaborative Discovery Programme (CDP) agreement....

Read more

Relief Therapeutics Announces European Patent Office Decision to Grant Patent for RLF-TD011

February 11, 2025 1:20 AM

RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announced that the European Patent Office (EPO) has issued a Decision to Grant for its patent application titled "Therapeutic Uses of Oxidizing Hypotonic Acid Solutions." This patent will protect therapeutic applications...

Read more

Onco-Innovations' Licensed PNKP Inhibitor Technology Shown to Increase Sensitivity of Cancer Cells to Radiation in Animal Study

February 10, 2025 7:00 PM

Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H ,WKN:A3EKSZ) ("Onco" or the "Company") is pleased to provide information on its exclusive-licensed technology, a new class of Polynucleotide Kinase 3'-Phosphatase (PNKP) inhibitors (the "Technology"), which demonstrated promising results in enhancing the sensitivity of cancer cells to radiation in an in vivo study 1 (the "Study") published in December, 2021, entitled, "Nano-Delivery of a Novel...

Read more

Jolt Health Inc. Announces Share Consolidation

February 10, 2025 4:10 PM

Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT)(FSE:G1Q0) announces it intends to proceed with a consolidation of its common shares (each, a "Share") on the basis of twenty (20) pre-consolidation Shares for one (1) post-consolidation Share (the "Consolidation"). The shareholders approved the Consolidation at the Annual and Special Meeting held on December 30, 2024, and the Board of Directors approved and confirmed the consolidation...

Read more

Black Book Research Releases First Industry-Wide Evaluation of AI-Driven Revenue Cycle Management Solutions

February 10, 2025 4:00 PM

Black Book Market Research, a leading independent healthcare research firm, has published its first comprehensive industry review of artificial intelligence (AI) applications in Revenue Cycle Management (RCM). This highly anticipated report, AI in Healthcare Finance: 2025 Market Review, is the first in a series that will examine the expectations, performance, and initial return on investment (ROI) of AI-driven healthcare delivery and financial...

Read more

Dr. Javad Sajan Secures Insurance Coverage For Liposuction and Fat Transfer to the Buttock (BBL) for Transgender Patients

February 10, 2025 2:10 PM

As Allure Esthetic and top Seattle plastic surgeon Dr. Javad Sajan continues to advocate for insurance coverage for liposuction and fat transfer to the buttocks, they are thrilled to announce that they have achieved another major step forward in insurance coverage for gender-affirming surgeries. Allure Esthetic successfully secured insurance coverage under major private insurance companies for gender-affirming liposuction and fat transfer to the...

Read more

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

February 10, 2025 1:30 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the filing of two new patent applications, covering groundbreaking developments in the treatment of glioma, an aggressive...

Read more

From Watts to Water: MilliporeSigma Projected To Conserve Over 24,000 MWh and 124,000 Cubic Meters of Water Through Energy and Water Efficiency Investments

February 10, 2025 11:00 AM

It's official - 2024 was the hottest year on record. With global temperatures at 1.28 degrees Celsius above NASA's 20th-century baseline (1951-1980) - topping the recording set in 2023 - the need to invest in resource conversation is more critical than ever.As a leading science and technology company, Merck KGaA, Darmstadt, Germany, is continuing its accelerated emissions reduction. The company's Group-wide and Life Science Sustainability...

Read more

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

February 10, 2025 9:45 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the appointment of Dimitris Moraitis as Vice President of Strategy & Operations.Mr. Moraitis brings over 25 years of...

Read more

DaVita Supports Thousands of Patients and Teammates Affected by Southern California Wildfires

February 10, 2025 9:45 AM

DaVita, a comprehensive kidney care provider, has activated its emergency response plan as devastating wildfires spread across Southern California. DaVita's emergency response plan includes:Accounting for patients and teammates (employees), assessing facilities in the affected areas and identifying safe shelters.Transferring patients to centers that can safely provide dialysis treatment.Providing patients with relevant medical...

Read more

Consensus Health Names Christine Hayek Chief Operating Officer

February 10, 2025 9:00 AM

Consensus Health, a leading New Jersey-based healthcare organization with a physician-led medical group and an Independent Physician Alliance (IPA), announced today the appointment of Christine Hayek to the post of chief operating officer. Christine Hayek, Chief Operating Officer, Consensus HealthHayek brings more than 25 years of healthcare operational experience to her new role. As COO, Hayek will be responsible for working closely with...

Read more

An Incredible KLAS Triple-Award Win for AGFA HealthCare!

February 10, 2025 9:00 AM

MORTSEL, BE / ACCESS Newswire / February 10, 2025 / AGFA HealthCare proudly celebrates a remarkable KLAS triple-win, securing two #1 Best in KLAS Awards for XERO® Viewer and VNA, alongside the KLAS Most Improved Software Product for 2025."To receive a KLAS Award is one of the most notable wins for AGFA HealthCare, and a testament to the hard work we invest into our flagship platform. More importantly, it reflects the trust and recognition from...

Read more

Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program

February 10, 2025 8:00 AM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals ("Salix"), today announced the opening of the 2025 Salix Gastrointestinal Health Scholars Program application period. The program will award 10 exceptional students living with GI disease a scholarship of up to $10,000 as they work to pursue their higher education goals."For the sixth consecutive year, Bausch Health is honored to offer...

Read more

CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference

February 10, 2025 8:00 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will present at the BIO CEO & Investor Conference being held February 10-11, 2025 in New York, NY.Details of the presentation are as...

Read more

Eviva Partners, a New Nonprofit Promoting Better Understanding of Medical Evidence, Exposes Role of Andrew Wakefield in the “Manufacture of Evidence” Leading Up to Robert F. Kennedy Jr’s Confirmation Hearings

February 10, 2025 7:50 AM

Eviva Partners, a pioneering healthcare initiative founded by physician-scientist Alex Morozov, announced its launch today with an innovative mission to address critical gaps in healthcare delivery through "evidence fluency" - a new framework for understanding and communicating medical evidence."The new US Administration is poised to have a dramatic impact on the integrity of scientific publications and medical evidence," said Alex Morozov, CEO...

Read more

Theralase(R) Releases Latest Research on Inactivation of Herpes Simplex Viruses

February 10, 2025 7:00 AM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that independent research conducted at the University of Manitoba has...

Read more

Key FDA Marijuana Response, MMJ International Holdings Advances Cannabis-Derived Therapeutics for Huntington’s Disease

February 10, 2025 6:00 AM

MMJ International Holdings, a trailblazer in cannabis-derived drug development, has reached a pivotal juncture in its quest to bring MMJ-002-a proprietary soft gelatin capsule combining THC, CBD, and other phytocannabinoids-to market for Huntington's disease (HD). The company recently completed a critical submission to the U.S. Food and Drug Administration (FDA), marking a milestone in its pursuit of the first FDA-approved natural cannabis...

Read more